Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 5:39 PM
Ignite Modification Date:
2025-12-25 @ 3:09 PM
NCT ID:
NCT05780268
Group ID:
EG000
Title:
LY3819253 Plus SOC
Description:
* LY3819253 7000 mg solution (10 vials of 20 mL solution containing 700 mg each); administered by IV infusion
* Remdesivir is provided to all study participants as SOC unless contraindicated for an individual patient; administered by IV infusion
LY3819253: LY3819253 is a neutralizing immunoglobulin G (IgG)-1 monoclonal antibody (mAb) to the receptor binding domain (RBD) of the S protein of SARS-CoV-2
Remdesivir: Antiviral agent
Deaths Number Affected:
13
Deaths Number At Risk:
None
Serious Number Affected:
9
Serious Number At Risk:
163
Other Number Affected:
41
Other Number At Risk:
163
Study:
NCT05780268
Results Section:
NCT05780268
Adverse Events Module:
NCT05780268